Aemetis, Inc. (NASDAQ:AMTX) Receives $12.95 Consensus PT from Analysts

Shares of Aemetis, Inc. (NASDAQ:AMTX) have been given a consensus rating of “Moderate Buy” by the five analysts that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $12.95.

A number of equities analysts have recently issued reports on AMTX shares. StockNews.com upgraded shares of Aemetis to a “sell” rating in a research report on Friday, January 3rd. HC Wainwright reiterated a “buy” rating and issued a $28.00 price objective on shares of Aemetis in a research report on Monday, December 23rd.

Hedge Funds Weigh In On Aemetis

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. FMR LLC grew its position in Aemetis by 68.2% in the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after buying an additional 9,137 shares during the last quarter. Hutchinson Capital Management CA acquired a new stake in Aemetis in the second quarter valued at $70,000. Barclays PLC lifted its holdings in Aemetis by 274.6% in the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock valued at $109,000 after acquiring an additional 34,816 shares during the period. Rhumbline Advisers lifted its holdings in Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after acquiring an additional 50,528 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in Aemetis by 7.7% in the third quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock valued at $2,126,000 after acquiring an additional 66,031 shares during the period. 27.02% of the stock is currently owned by hedge funds and other institutional investors.

Aemetis Trading Down 2.8 %

Shares of AMTX opened at $2.82 on Monday. The firm has a market cap of $140.25 million, a PE ratio of -1.25 and a beta of 1.47. The company’s 50 day simple moving average is $3.28 and its 200-day simple moving average is $2.97. Aemetis has a 12-month low of $2.10 and a 12-month high of $7.03.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to analysts’ expectations of $77.79 million. During the same quarter last year, the business posted ($0.59) earnings per share. As a group, equities research analysts forecast that Aemetis will post -2.02 EPS for the current fiscal year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.